Abstract
Tricuspid annular (TA) size, assessed by 2D transthoracic echocardiography (TTE), has a well-established prognostic value in patients undergoing mitral valve surgery, with TA dilatation triggering simultaneous tricuspid annuloplasty. While TA dilatation is common in patients with dilated atria secondary to atrial fibrillation, little is known about the mechanisms of TA dilatation in patients with sinus rhythm (SR). This study aimed to identify echocardiographic parameters most closely related to the TA size as a potential tool for identification of patients prone to developing TA enlargement. 120 patients with SR underwent clinically indicated TTE, including 30 patients with normal hearts and 90 patients diagnosed with at least one right heart abnormality, defined as: right ventricular (RV) or right atrial (RA) dilatation, ≥ moderate tricuspid regurgitation (TR) and elevated systolic pulmonary artery pressure (sPAP). RA and RV end-diastolic and end-systolic volumes (EDV, ESV) and function were measured using commercial 3D software (TomTec). 3D RV long and short axes were used as surrogate indices of RV shape. Degrees of TR and sPAP were estimated by 2D TTE. 3D TA sizing was performed at end-diastole using 3D custom software. Linear regression analysis was used to identify variables best correlated with TA size, followed by multivariate analysis to identify independent associations. The highest correlations were found between TA area and: RA ESV (r = 0.73; p < 0.01), RV EDV (r = 0.58; p < 0.01), RV end-diastolic long and short axes (r = 0.53, 0.42; both p < 0.01), TR degree (r = 0.40; p < 0.01) and sPAP (r = 0.32; p < 0.01). Multivariate analysis revealed that RA ESV was the only parameter independently associated with TA area (p < 0.05, r = 0.85). In conclusion, RA volume plays an important role in TA dilatation even in patients with normal SR. Understanding of annular remodeling mechanisms could aid in identifying patients at higher risk for TA dilatation, especially those scheduled for mitral valve surgery.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Echocardiographic assessment of tricuspid annular (TA) dimensions should be standard practice in the evaluation of patients with mitral valve disease and severe mitral regurgitation (MR), who are considered for valve surgery [1, 2]. Recent studies showed that TA sizing may be important in patients undergoing percutaneous mitral valve (MV) repair, who may benefit from simultaneous tricuspid valve (TV) annuloplasty [3, 4]. Specifically, in patients with atrial fibrillation, atrial enlargement plays a predominant role in bilateral annular dilatation [5]. However, in patients with normal sinus rhythm (SR), the mechanisms of TA dilatation are not well understood, and accordingly, the ability to predict severe TA dilatation is limited. Per current guidelines, the presence of more than moderate tricuspid regurgitation (TR) in patients with severe MR identifies those at higher mortality risk [6,7,8], justifying concomitant tricuspid annuloplasty [1, 2, 9,10,11]. Moreover, in patients undergoing MV surgery, future development of significant TR as an epiphenomenon of TA dilatation [12], has led to considering isolated annular enlargement as an indication for simultaneous TV repair, as recommended by current guidelines [1].
Despite the fact that simultaneous tricuspid annuloplasty improves functional TR parameters, data regarding long-term mortality are inconsistent [13, 14]. However, previous studies have shown that with adequate patient selection [1], the strategy of routine tricuspid annuloplasty significantly reduces TR, contributing to beneficial long-term right heart remodeling [13]. Nevertheless, at the time of left valve surgery, the number of patients eligible for simultaneous TV repair ranges between 6 and 60% [13], underscoring that in these patients, right heart remodeling may have already occurred [15]. Importantly, despite repair of the left sided valvular abnormality, TA remodeling is a dynamic process that is usually not alleviated by isolated treatment of the mitral valve disease [16]. Nowadays there is insufficient data regarding the selection of patients suitable for tricuspid repair at the time of MV surgery, in whom right heart remodeling has already occurred [17, 18]. Identification of these patients may be helpful for mitigating the risk for TA dilatation and subsequent TR development. However, this requires better understanding of the mechanisms of TA enlargement.
Echocardiographic assessment of the TA plays a crucial role in patients excluded from simultaneous tricuspid annuloplasty. Current TA measurements rely on two-dimensional (2D) transthoracic echocardiography (TTE) [1, 2], which is intrinsically limited by its view dependency, resulting in underestimation of annular dimensions when compared to three-dimensional (3D) assessment [19, 20]. Moreover, 2D echocardiographic TA measurements have higher inter-observer variability, often making the follow-up of TA dimensions equivocal [21]. Methodology-related underestimation of TA dimensions is a known pitfall in annular measurements and also a confounding factor in the evaluation of the mechanisms of TA enlargement. Recent studies suggest that these limitations may be easier to overcome with the use of 3D echocardiography [21]. Accordingly, the aim of this study was to identify 3D echocardiographic parameters most closely related to TA dimensions, as a potential tool for early identification of patients with higher probability of impending annular enlargement.
Methods
This retrospective study included 128 patients, referred for clinically indicated TTE at two institutions, the University of Chicago Medical Center (Chicago, Illinois, USA) and the Cardiologic Center Monzino (Milan, Italy) between June 2017 and June 2018. Enrolment criteria were based on echocardiographic diagnosis of normal heart or primary or secondary right-heart disease, with at least one right-heart abnormality. Patients were excluded if they had cardiac arrhythmias, pacemakers, previous cardiac surgery, congenital heart disease or poor endocardial border visualization, which was defined as the lack of visualization of 3 contiguous segments using a 17-segment model of the left ventricle, as well as incomplete visualization of the right ventricular (RV) free wall and both atria. Thus, only 3D datasets in which TA boundaries could be traced with confidence by an experienced investigator and accurately detected by semi-automated software, were used. According to current guidelines [1, 22], right heart abnormalities were defined on 2D and 3D [20, 22,23,24,25] images as: RV dilatation and/or dysfunction, RA dilatation, ≥ moderate tricuspid regurgitation and elevated systolic pulmonary artery pressure (sPAP). The Institutional Review Boards of both Institutions approved the study, and informed consent was obtained from each patient. Analysis was performed at the University of Chicago Medical Center.
A comprehensive 2D echocardiographic examination was performed using a commercial ultrasound system (i33 or Epiq7, Philips Healthcare, Andover, MA) equipped with an X5-1 probe. After optimization of 2D images by adjusting the depth, gain and time-gain compensation, 3D full-volume datasets of right heart chambers were obtained from the RV-focused apical 4-chambers view using electrocardiographic gating over two consecutive cardiac cycles during held end-expiration. The frame rate of the 3D datasets was optimized by adjusting the elevation and sector width.
First, right heart chambers’ linear dimensions were assessed on 2D images, using the RV-focused apical 4-chambers view. The single-plane disks summation method was used for RA volume determination at end-systole; whereas end-diastolic and end-systolic indexed areas were used for the assessment of RV size. According to current recommendations [22], RA enlargement using 2D imaging was defined as a volume > 27 and 32 ml/m2 for female and male patients, respectively. Using 3D imaging, RA volumes of > 38 and 49 ml/m2 for females and males, respectively, were used as cutoffs for enlargement [20]. RV systolic function was assessed using fractional area change (FAC), tricuspid annular plane systolic excursion (TAPSE) on M-Mode images and S′-wave velocity by tissue Doppler imaging [22]. According to guidelines [22], RV dilation was defined as RV end-diastolic indexed area > 11.5 or 12.6 cm2/m2 for females and males, respectively. RV dysfunction was defined as TAPSE < 17 mm or S′-wave velocity < 9.5 cm/s or FAC < 35% for 2D. RV dysfunction using 3D was defined as an RV ejection fraction (EF) < 45%. SPAP and TR degree were assessed as recommended by current guidelines [1, 2]; elevated sPAP was defined as values > 37 mmHg [22]. TR degree was quantified based on the dimensions of the vena contracta (VC) and the dimension of the radius of the regurgitant jet using the proximal isovelocity surface area (PISA) method in either the RV inflow, apical 4-chamber or the RV-focused apical 4-chamber views. For TR classification, the echocardiographic view showing the largest VC dimensions or PISA radius was chosen. The hepatic vein flow by pulsed-wave Doppler in the subcostal view was also used, when available, for better classification of TR. TR severity was graded as: 0 = absent, 1 = trivial, 2 = mild, 3 = mild to moderate, 4 = moderate, 5 = moderate to severe, 6 = severe [1, 2].
Thereafter, 3D analysis was performed offline using commercial software (TomTec, Unterschleissheim, Germany). End-diastolic and end-systolic RV volumes were obtained using semi-automated software (TomTec 4D RV-Analysis) (Fig. 1). End-diastolic and end-systolic RA volumes were obtained using the LV analysis algorithm (TomTec 4D LV-Analysis) adapted for 3D atrial measurements, as previously described [23] (Fig. 2). The 3D atrial and ventricular EFs were then calculated. Moreover, RV analysis also provided measurements of 3D end-diastolic long and basal axes, that were used as surrogate measures of RV shape. RV free-wall and septal peak-systolic strains were also assessed using semi-automated software for RV analysis (Fig. 1).
Finally, 3D TA measurements, including area, perimeter and long axis, were performed using previously described custom software [24] at end-diastole, defined as the frame just prior to TV leaflet closure. Briefly, the software allows 3D reconstruction of the annulus along all three spatial dimensions. After manual orientation of orthogonal and cross-sectional planes to optimize TV visualization, the software exports a 3D full-volume dataset into Cartesian coordinates. The 3D dataset is then used to extract several 2D planes, containing the TV, each one rotated around the RA-RV direction. The software automatically detects the TV insertion points (hinge points) on each 2D plane, allowing a complete 3D reconstruction of the annular geometry. Manual correction of the hinge points was performed as needed, depending on the quality of the 3D dataset (Fig. 3).
Since there are no guidelines-recommended 3D cutoff values for the diagnosis of TA enlargement, normal annular dimensions were defined based on the largest available study that reported annular dimensions in normal volunteers [24]. Indexed axes, perimeter and area were used to evaluate the normality of annular size in male and female subjects. The annulus was defined as normal when at least three dimensions among indexed long axis, short axis, perimeter and area were within the normal ranges [24].
Statistical analysis
Statistical analysis was performed using SPSS software (SPSS Inc., Chicago, IL, USA). Continuous variables are presented as mean ± SD. Categorical data are presented as percentages or absolute numbers. Linear regression analysis with Pearson’s correlation was used to identify echocardiographic variables that correlated best with TA dimensions. 3D end-diastolic TA area, perimeter and long axis were correlated to each of the following 3D dependent variables: end-diastolic and end-systolic RA volumes, RA EF, end-diastolic and end-systolic RV volumes, RV EF, RV long and basal axes, RV free wall strain, RV septal strain. Moreover, linear regression was performed between end-diastolic annular area, perimeter and long axis and sPAP, as well as degree of TR. Same analyses were repeated using indexed TA dimensions (area, perimeter and long axis) and indexed right-chambers volume and axes (end-diastolic and end-systolic RA and RV volumes, RV long and basal axes). Variables showing the highest correlations (r > 0.30) with statistical confidence (p < 0.01) with TA dimensions were selected for the multivariate analysis, which was used to identify independent associations among the selected variables. A pre-test analysis of variance (F-statistic, < 5%) was performed to test the null hypothesis.
Results
After excluding 8 patients from the initial cohort of 128, due to poor 3D image quality, the final study group consisted of 120 patients. This included 30 patients with normal hearts and 90 patients diagnosed with at least one right heart abnormality. The baseline characteristics of study subjects are presented in Table 1. The average frame rate of 3D images was 26 ± 11 Hz. Manual correction of TA hinge points was required in the majority of patients (n = 108, 90%).
Among patients with right heart disorders, 78 (87%) had secondary and 12 (13%) primary right heart disease due to pulmonary arterial hypertension. These patients were categorized as shown in Table 2. The echocardiographic characteristics of the study subjects are shown in Table 3. Based on previous data, 77 patients (64%) could be determined to have normal gender-related 3D TA dimensions, including 32 (67%) males and 45 (62%) females [24].
When compared to annular perimeter and long axis, end-diastolic TA area showed the best correlation with the majority of the echocardiographic variables. Subsequently, end-diastolic TA area was chosen as the independent variable. To avoid collinearity on multivariate analysis, only the RV end-diastolic (maximal) volume and the RA end-systolic (maximal) volume were entered into the multivariate model; both variables showed higher correlations with TA area compared to RV end-systolic and RA end-diastolic volumes.
Results of univariate regression analyses are presented in Table 4. Linear regression analysis showed an appreciable association between RV end-diastolic volume and TA area, perimeter and long axis, with the highest correlation noted between RV volume and TA area (r = 0.58, p < 0.001; Fig. 4, top left). Correlation coefficients between RV systolic function and TA dimensions (area, perimeter and area) were low; this also included RV free-wall and septal strain. Analysis of RV long and basal axes showed an association between these variables and TA area (Fig. 4, top right and middle left, respectively), perimeter and long axis; correlations were slightly higher when TA area was used (r = 0.53, p < 0.001 for long axis; r = 0.42, p < 0.001 for basal axis).
RA end-systolic (maximal) and end-diastolic volumes correlated well with TA dimensions, with the highest correlation noted between RA end-systolic volume and TA area (r = 0.73, p < 0.001; Fig. 4, middle right). The correlations between the degree of TR and the three TA dimensions were weaker (r = 0.40, p < 0.001 for both TA area and long axis) (Fig. 4, bottom left). Similarly, the degree of sPAP and TA dimensions revealed a low correlation between these parameters (r < 0.4, p < 0.001 for TA area, perimeter and long axis) (Fig. 4, bottom right).
Linear regression analyses between each of the TA indexed dimensions (area, perimeter and long axis) and indexed RV volume, RA volume and RV axes showed the same trend as noted with the non-indexed variables (Table 4), while for the non-indexed variables, the correlations were lower than between indexed echocardiographic variables and TA indexed area, compared to indexed TA perimeter and axis.
Multivariate analysis (Table 5, bottom) showed that only RA end-systolic volume was independently associated with TA end-diastolic area (p < 0.001). In contrast, neither RV end-diastolic volume nor RV axes, degree of TR and sPAP were independently associated with TA size (p > 0.05).
Discussion
In this study, we investigated the echocardiographic variables associated with the 3D TA dimensions enlargement in a heterogeneous cohort of patients with normal SR. Our results showed that patients with larger TA areas have larger RA volumes, suggesting that atrial enlargement may be a critical factor in annular dilatation even in patients without atrial fibrillation.
Despite the role of TA enlargement in the development of TR, few data are available regarding the mechanisms of TA dilatation [16]. It has been shown that both RA and TA enlargement appear to be triggered by severe TR, but no data is available regarding the synergistic role of right-heart chamber volumes, TR severity and pulmonary pressure in TA remodeling [25]. In patients with atrial fibrillation, the predominant role of RA volume in determining annular dimensions has been demonstrated previously [5]. Our results underline the dependency of TA enlargement on RA size, also in patients with SR. Surprisingly, RV volumes and RV long-axis dimension, used as surrogate indices of RV shape, seem to play a secondary role in modulating TA dimensions.
In our study group, 31 patients (26%) were diagnosed with moderate to severe TR, but TR severity did not strongly correlate with TA enlargement. The progression of TR is associated with different pathophysiological mechanisms [26, 27]; particularly, TR is a continuum of two main mechanisms. On one hand, TR could be related to leaflet tethering without significant annular enlargement, a common finding in patients with pulmonary hypertension [28]. On the other hand, TR may be the result of significant annular dilatation without TV leaflet involvement, as can be found in patients with atrial fibrillation [12]. To further complicate matters, the development of TR may over time result in RA dilatation, and, as a consequence, TR may contribute towards progressive TA enlargement that worsens regurgitation. Finally, TR degree is also strongly dependent on the hemodynamic status of the patient, based on loading conditions. In our study, TR severity was not independently associated with TA dimension. This may be due to the wide spectrum of mechanisms contributing to TR development and explaining the fact that patients with significant TR do not necessarily have dilated TA and vice-versa. Thus, it seems that TR may contribute to TA dilatation via RA enlargement, which results in aggravation of annular dilatation and TR degree in a sort of feedback loop reaction.
Surprisingly, in our study, RV volumes appeared not to be significantly related to TA dimensions. This may be due to the fact that patients enrolled in our study had different pathologies which affected RV volumes and geometry differently. Thus, RV remodeling may be different among patients, depending on the underlying disease, making the annular size to be influenced by the ventricle based on the type and degree of RV remodeling. Only patients in whom the RV remodeling predominantly affects the medio-basal segments may develop a significant annular dilatation determined by the ventricle rather than the atrium. This may explain the fact that, similar to the TR degree, in our multivariate model, RV volumes and axes were not independently associated with TA dimensions.
Understanding the mechanisms of TA dilatation may be of particular importance based on the well-established prognostic role played by annular dimensions in patients undergoing MV surgery [9]. Previous data showed that TR progression after isolated MV surgery is closely related to annular dilatation [29]. However, at the time of MV repair, the eligibility of patients for simultaneous tricuspid annuloplasty is based on a ‘single’ static evaluation of 2D TA dimensions. Since TA remodeling is a dynamic process, identification of patients at higher risk of future TA enlargement after left-heart surgery, may be helpful in the management of this subgroup of patients.
The presence of RA enlargement in patients with SR undergoing MV surgery could potentially be used as a predictor of possible TA dilatation and TR development, highlighting the need for a closer echocardiographic and clinical follow-up of these patients. In fact, based on the established high mortality risk of TV surgery after isolated left-sided valvular repair, current guidelines recommend that treatment of late secondary severe TR be performed earlier, particularly if signs of progressive RV dilatation or dysfunction are present, even in asymptomatic patients [1]. Early identification of these patients is crucial, thus the presence of echocardiographic predictors for TA dilatation may trigger a different post-surgical management in this population.
Another interesting point is the recurrence of significant TR after annuloplasty, that is diagnosed in 8–15% of patients after MV surgery [30, 31]. Our study did not investigate the role of RA volume in these patients, however, further studies are needed to identify which parameters are closely related to TA repair failure.
Limitations
Our study was retrospective in nature and the study group was relatively small. Another limitation is the heterogeneity of our population, including a wide variety of different diseases involving the right heart. To circumvent this limitation, we categorized patients into different classes based on the underlying diseases, however the percentage of patients in each category was not equal. TA dimensions were measured using custom software, which is not universally available.
Conclusions
RA volume plays an important role in TA dilatation, irrespective of the presence of atrial fibrillation. The understanding of annular remodeling mechanisms could be of particular importance in identifying patients with higher probability of TA dilatation whose annular dimensions are crucial at the time of surgical decision-making prior to mitral valve surgery. Particularly, among patients in sinus rhythm undergoing isolated MV repair, the presence of RA enlargement may highlight a subgroup of patients at higher risk of TA enlargement, underscoring the potential need for close post-surgical echocardiographic follow-up.
Abbreviations
- EF:
-
Ejection fraction
- FAC:
-
Fractional area change
- MR:
-
Mitral regurgitation
- MV:
-
Mitral valve
- PISA:
-
Proximal isovelocity surface area
- SR:
-
Sinus rhythm
- sPAP:
-
Systolic pulmonary artery pressure
- 3D:
-
Three-dimensional
- TA:
-
Tricuspid annular
- TAPSE:
-
Tricuspid annular plane systolic excursion
- TR:
-
Tricuspid regurgitation
- TV:
-
Tricuspid valve
- 2D:
-
Two-dimensional
- RV:
-
Right ventricular
- VC:
-
Vena contracta
References
Baumgartner H, Falk V, Bax JJ et al (2017) 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791
Nishimura RA, Otto CM, Bonow RO et al (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 70:252–289
Asmarats L, Puri R, Latib A et al (2018) Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol 71:2935–2956
Hausleiter J, Braun D, Orban M et al (2018) Patient selection, echocardiographic screening and treatment strategies for interventional tricuspid repair using the edge-to-edge repair technique. EuroIntervention 14:645–653
Utsunomiya H, Itabashi Y, Mihara H et al (2017) Functional tricuspid regurgitation caused by chronic atrial Fibrillation: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging 10:e004897
Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405–409
Koelling TM, Aaronson KD, Cody RJ et al (2002) Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144:524–529
Topilsky Y, Nkomo VT, Vatury O et al (2014) Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 7:1185–1194
Benedetto U, Melina G, Angeloni E et al (2012) Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. J Thorac Cardiovasc Surg 143:632–638
Dreyfus GD, Corbi PJ, Chan KM et al (2005) Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 79:127–132
Van de Veire NR, Braun J, Delgado V et al (2011) Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. J Thorac Cardiovasc Surg 141:1431–1439
Shiran A, Sagie A (2009) Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 53:401–408
Chikwe J, Itagaki S, Anyanwu A et al (2015) Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol 65:1931–1938
Pettinari M, De Kerchove L, Lazam S et al (2018) Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery†. Eur J Cardiothorac Surg 55(5):851–858
Seeburger J, Borger MA, Falk V et al (2008) Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg 34:760–765
Fukuda S, Saracino G, Matsumura Y et al (2006) Three-dimensional geometry of the tricuspid annulus in healthy subjects and in patients with functional tricuspid regurgitation: a real-time, 3-dimensional echocardiographic study. Circulation 114:I492–I498
Duran CM, Pomar JL, Colman T et al (1980) Is tricuspid valve repair necessary? J Thorac Cardiovasc Surg 80:849–860
Kara I, Koksal C, Erkin A et al (2015) Outcomes of mild to moderate functional tricuspid regurgitation in patients undergoing mitral valve operations: a meta-analysis of 2488 patients. Ann Thorac Surg 100:2398–2407
Miglioranza MH, Mihăilă S, Muraru D et al (2015) Variability of tricuspid annulus diameter measurement in healthy volunteers. JACC Cardiovasc Imaging 8:864–866
Miglioranza MH, Mihăilă S, Muraru D et al (2015) Dynamic changes in tricuspid annular diameter measurement in relation to the echocardiographic view and timing during the cardiac cycle. J Am Soc Echocardiogr 28:226–235
Volpato V, Lang RM, Yamat M et al (2019) Echocardiographic assessment of the tricuspid annulus: the effects of the third dimension and measurement methodology. J Am Soc Echocardiogr 32(2):238–247
Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28(1–39):e14
Tamborini G, Fusini L, Muratori M et al (2016) Right heart chamber geometry and tricuspid annulus morphology in patients undergoing mitral valve repair with and without tricuspid valve annuloplasty. Int J Cardiovasc Imaging 32:885–894
Addetia K, Muraru D, Veronesi F, et al. (2019) 3-Dimensional echocardiographic analysis of the tricuspid annulus provides new insights into tricuspid valve geometry and dynamics. J Am Coll Cardiol Cardiovasc Img 12:401–412. https://doi.org/10.1016/j.jcmg.2017.08.022
Nemoto N, Schwartz JG, Lesser JR et al (2017) The right atrium and tricuspid annulus are cardinal structures in tricuspid regurgitation with or without pulmonary hypertension. Int J Cardiol 230:171–174
Nemoto N, Lesser JR, Pedersen WR et al (2015) Pathogenic structural heart changes in early tricuspid regurgitation. J Thorac Cardiovasc Surg 150:323–330
Buzzatti N, De Bonis M, Moat N (2018) Anatomy of the tricuspid valve, pathophysiology of functional tricuspid regurgitation, and implications for percutaneous therapies. Interv Cardiol Clin 7:1–11
Medvedofsky D, Aronson D, Gomberg-Maitland M et al (2017) Tricuspid regurgitation progression and regression in pulmonary arterial hypertension: implications for right ventricular and tricuspid valve apparatus geometry and patients outcome. Eur Heart J Cardiovasc Imaging 18:86–94
Izumi C, Miyake M, Takahashi S et al (2011) Progression of isolated tricuspid regurgitation late after left-sided valve surgery. Clinical features and mechanisms. Circ J 75:2902–2907
Navia JL, Nowicki ER, Blackstone EH et al (2010) Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg 139(1473–82):e5
McCarthy PM, Bhudia SK, Rajeswaran J et al (2004) Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg 127:674–685
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
The study was approved by the Institutional Review Board with a waiver of consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Volpato, V., Mor-Avi, V., Veronesi, F. et al. Three-dimensional echocardiography investigation of the mechanisms of tricuspid annular dilatation. Int J Cardiovasc Imaging 36, 33–43 (2020). https://doi.org/10.1007/s10554-019-01686-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-019-01686-7